ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 470

Disease Outcome in Patients Fulfilling the 2010 Classification Criteria for Rheumatoid Arthritis: The Impact of the Different Criteria Components

Ellen Sauar Norli1,2, Gina Hetland Brinkmann2,3, Tore K. Kvien2, Olav Bjørneboe1, Anne Julsrud Haugen3, Halvor Nygaard4, Cathrine Thunem5, Elisabeth Lie2 and Maria Dahl Mjaavatten2, 1Dept. of Rheumatology, Martina Hansens Hospital, Sandvika, Norway, 2Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 3Dept. of Rheumatology, Østfold Hospital Trust, Fredrikstad, Norway, 4Dept. of Rheumatology, Lillehammer Hospital of Rheumatic Diseases, Lillehammer, Norway, 5Dept. of Rheumatology, Betanien Hospital, Skien, Norway

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: classification criteria and resolution of disease, Early Rheumatoid Arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Rheumatoid Arthritis - Clinical Aspects Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

The 2010 ACR/EULAR
classification criteria for rheumatoid arthritis (2010 RA criteria) facilitate
early classification of rheumatoid arthritis (RA). The criteria yield a score ranging
0-10, with the cut-off for definite RA set at 6 or more points. In general,
diagnostic certainty increases with an increasing number of criteria points.
Our objective was to study the 2-year outcome in a cohort of patients (pts)
with very early arthritis fulfilling the 2010 RA criteria at baseline,
according to the contribution from the 4 different criteria components (joint involvement,
serology, acute phase reactants, duration).

Methods:

1118 pts (age 18-75 years) with arthritis
of maximum 16 weeks’ duration were included in the NOR-VEAC (Norwegian Very
Early Arthritis Clinic) study from 2004 to 2010. All pts who fulfilled the 2010 RA criteria at baseline and had
follow-up data were included in the current analyses. Two clinical outcome
groups were defined: “Persistent disease” (pts prescribed with DMARDs, with a final
clinical diagnosis of RA and/or one or more swollen joints at last visit) and “self-limiting
arthritis” (no DMARD use ever, final clinical diagnosis not RA and no swollen
joints at last visit). The association between the components of the 2010 RA
criteria and outcome was examined by univariable and multivariable logistic
regression. Additionally, we performed subgroup analyses in the pts with only 6
criteria points.

Results:

Of the 256 pts fulfilling the 2010 RA
criteria (age 52.8±13.9 years, 63.3% females,
median (25-75 perc.) duration of joint swelling 63.5 (40.0-83.0) days, 57.4% anti-CCP
positive, DAS28 5.2±1.3), 36 had self-limiting arthritis.
The pts with self-limiting vs persistent disease more often had 5 joint involvement
points (77.8 vs 55.9%, p=0.013), 0 serology points (63.9 vs 24.5%, p<0.0005)
and 0 duration points (47.2 vs 22.3%, p=0.002). Multivariable logistic
regression showed that absence of serology points (OR 4.7, [2.2-10.1]) and duration points (OR 2.4, [1.1-5.1]) were independent predictors of self-limiting
arthritis.

A total of 66 pts had only 6 criteria points,
and 52.8% (19/36) of the pts with self-limiting arthritis belonged to this
group. When the 6 points consisted of 5 joint involvement points and 1 acute phase
point, 43.3% had self-limiting arthritis, as opposed to 16.7% for other 6-point
combos (p=0.017). Pts with an additional duration point (5 joint involvement points,
1 acute phase point and 1 duration point) less frequently had self-limiting
arthritis (19.5 vs 43.3%, p=0.03).

Conclusion:

In this study of 256 pts fulfilling the
2010 RA criteria at baseline, we found that not having a duration point or any serology
points were associated with self-limiting arthritis. Pts with 6 criteria points
made up by 5 joint involvement points and 1 acute phase point had a high
likelihood of having self-limiting arthritis during the 2-year follow-up.


Disclosure: E. S. Norli, None; G. H. Brinkmann, None; T. K. Kvien, None; O. Bjørneboe, None; A. J. Haugen, None; H. Nygaard, None; C. Thunem, None; E. Lie, None; M. D. Mjaavatten, None.

To cite this abstract in AMA style:

Norli ES, Brinkmann GH, Kvien TK, Bjørneboe O, Haugen AJ, Nygaard H, Thunem C, Lie E, Mjaavatten MD. Disease Outcome in Patients Fulfilling the 2010 Classification Criteria for Rheumatoid Arthritis: The Impact of the Different Criteria Components [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/disease-outcome-in-patients-fulfilling-the-2010-classification-criteria-for-rheumatoid-arthritis-the-impact-of-the-different-criteria-components/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/disease-outcome-in-patients-fulfilling-the-2010-classification-criteria-for-rheumatoid-arthritis-the-impact-of-the-different-criteria-components/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology